|
1
|
Christian KJ, Lang MA and Raffalli-Mathieu
F: Interaction of heterogeneous nuclear ribonucleoprotein C1/C2
with a novel cis-regulatory element within p53 mRNA as a response
to cytostatic drug treatment. Mol Pharmacol. 73:1558–1567. 2008.
View Article : Google Scholar
|
|
2
|
Sun W, Xing B, Sun Y, et al: Proteome
analysis of hepatocellular carcinoma by two-dimensional difference
gel electrophoresis. Mol Cell Proteomics. 6:1798–1808. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang J, Cho SJ, Shu L, et al:
Translational repression of p53 by RNPC1, a p53 target
overexpressed in lymphomas. Genes Dev. 25:1528–1543. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Merrill BM, Barnett SF, LeStourgeon WM and
Williams KR: Primary structure differences between proteins Cl and
C2 of HeLa 40S nuclear ribonucleoprotein particles. Nucleic Acids
Res. 17:8441–8449. 1989. View Article : Google Scholar
|
|
5
|
Izquierdo JM: Heterogeneous
ribonucleoprotein C displays a repressor activity mediated by
T-cell intracellular antigen-1-related/like protein to modulate Fas
exon 6 splicing through a mechanism involving Hu antigen R. Nucleic
Acids Res. 38:8001–8014. 2010. View Article : Google Scholar
|
|
6
|
Nakielny S and Dreyfuss G: The hnRNP C
proteins contain a nuclear retention sequence that can override
nuclear export signals. J Cell Biol. 134:1365–1373. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Velusamy T, Shetty P, Bhandary YP, Liu MC
and Shetty S: Posttranscriptional regulation of urokinase receptor
expression by heterogeneous nuclear ribonuclear protein C.
Biochemistry. 47:6508–6517. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shetty S: Regulation of urokinase receptor
mRNA stability by hnRNP C in lung epithelial cells. Mol Cell
Biochem. 272:107–118. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee EK, Kim HH, Kuwano Y, et al: hnRNP C
promotes APP translation by competing with FMRP for APP mRNA
recruitment to P bodies. Nat Struct Mol Biol. 17:732–739. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim JH, Paek KY, Choi K, et al:
Heterogeneous nuclear ribonucleoprotein C modulates translation of
c-myc mRNA in a cell cycle phase-dependent manner. Mol Cell Biol.
23:708–720. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Blume SW, Jackson NL, Frost AR, et al:
Northwestern profiling of potential translation-regulatory proteins
in human breast epithelial cells and malignant breast tissues:
evidence for pathological activation of the IGF1R IRES. Exp Mol
Pathol. 88:341–352. 2010. View Article : Google Scholar
|
|
12
|
Hossain MN, Fuji M, Miki K, Endoh M and
Ayusawa D: Downregulation of hnRNP C1/C2 by siRNA sensitizes HeLa
cells to various stresses. Mol Cell Biochem. 296:151–157. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meng Z, Jackson NL, Choi H, King PH,
Emanuel PD and Blume SW: Alterations in RNA-binding activities of
IRES-regulatory proteins as a mechanism for physiological
variability and pathological dysregulation of IGF-IR translational
control in human breast tumor cells. J Cell Physiol. 217:172–183.
2008. View Article : Google Scholar
|
|
14
|
Ariizumi T, Ogose A, Kawashima H, Hotta T,
Umezu H and Endo N: Multinucleation followed by an acytokinetic
cell division in myxofibrosarcoma with giant cell proliferation. J
Exp Clin Cancer Res. 28:442009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Blanchard Z, Malik R, Mullins N, et al:
Geminin overexpression induces mammary tumors via suppressing
cytokinesis. Oncotarget. 2:1011–1027. 2011.PubMed/NCBI
|
|
16
|
Margall-Ducos G, Celton-Morizur S, Couton
D, Brégerie O and Desdouets C: Liver tetraploidization is
controlled by a new process of incomplete cytokinesis. J Cell Sci.
120(Pt 20): 3633–3639. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Toyoda H, Bregerie O, Vallet A, et al:
Changes to hepatocyte ploidy and binuclearity profiles during human
chronic viral hepatitis. Gut. 54:297–302. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Studach LL, Rakotomalala L, Wang WH, et
al: Polo-like kinase 1 inhibition suppresses hepatitis B virus X
protein-induced transformation in an in vitro model of liver cancer
progression. Hepatology. 50:414–423. 2009. View Article : Google Scholar
|
|
19
|
Hsieh SY, Huang SF, Yu MC, et al:
Stathmin1 overexpression associated with polyploidy, tumor-cell
invasion, early recurrence, and poor prognosis in human hepatoma.
Mol Carcinog. 49:476–487. 2010.PubMed/NCBI
|
|
20
|
Xu Z, Ogawa H, Vagnarelli P, et al:
INCENP-aurora B interactions modulate kinase activity and
chromosome passenger complex localization. J Cell Biol.
187:637–653. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Petsalaki E, Akoumianaki T, Black EJ,
Gillespie DA and Zachos G: Phosphorylation at serine 331 is
required for Aurora B activation. J Cell Biol. 195:449–466. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Emanuele MJ, Lan W, Jwa M, Miller SA, Chan
CS and Stukenberg PT: Aurora B kinase and protein phosphatase 1
have opposing roles in modulating kinetochore assembly. J Cell
Biol. 181:241–254. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yan J, Jin S, Li J and Zhan Q: Aurora B
interaction of centrosomal Nlp regulates cytokinesis. J Biol Chem.
285:40230–40239. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mora-Bermudez F, Gerlich D and Ellenberg
J: Maximal chromosome compaction occurs by axial shortening in
anaphase and depends on Aurora kinase. Nat Cell Biol. 9:822–831.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Miyauchi K, Zhu X, Foong C, Hosoya H and
Murata-Hori M: Aurora B kinase activity is required to prevent
polar cortical ingression during cytokinesis. Cell Cycle.
6:2549–2553. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Song SJ, Kim SJ, Song MS and Lim DS:
Aurora B-mediated phosphorylation of RASSF1A maintains proper
cytokinesis by recruiting Syntaxin16 to the midzone and midbody.
Cancer Res. 69:8540–8544. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Delaval B, Ferrand A, Conte N, et al:
Aurora B -TACC1 protein complex in cytokinesis. Oncogene.
23:4516–4522. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
You J, Li Q, Wu C, Kim J, Ottinger M and
Howley PM: Regulation of aurora B expression by the bromodomain
protein Brd4. Mol Cell Biol. 29:5094–5103. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qi G, Ogawa I, Kudo Y, et al: Aurora-B
expression and its correlation with cell proliferation and
metastasis in oral cancer. Virchows Arch. 450:297–302. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hauf S, Cole RW, LaTerra S, et al: The
small molecule Hesperadin reveals a role for Aurora B in correcting
kinetochore-microtubule attachment and in maintaining the spindle
assembly checkpoint. J Cell Biol. 161:281–294. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang Y, Sun DQ and Liu DG: Tumor
suppression by RNA from C/EBPβ 3′UTR through the inhibition of
protein kinase Cε activity. PLoS One. 6:e165432011.
|
|
32
|
Peritz T, Zeng F, Kannanayakal TJ, et al:
Immunoprecipitation of mRNA-protein complexes. Nat Protoc.
1:577–580. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yanagiya A, Suyama E, Adachi H, et al:
Translational homeostasis via the mRNA cap-binding protein, eIF4E.
Mol Cell. May 10–2012.(Epub ahead of print).
|
|
34
|
Ding ZB, Shi YH, Zhou J, et al:
Association of autophagy defect with a malignant phenotype and poor
prognosis of hepatocellular carcinoma. Cancer Res. 68:9167–9175.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Couto SS, Griffey SM, Duarte PC and
Madewell BR: Feline vaccine-associated fibrosarcoma: morphologic
distinctions. Vet Pathol. 39:33–41. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ganem NJ, Storchova Z and Pellman D:
Tetraploidy, aneuploidy and cancer (Review). Curr Opin Genet Dev.
17:157–162. 2007. View Article : Google Scholar
|
|
37
|
Guse A, Mishima M and Glotzer M:
Phosphorylation of ZEN-4/MKLP1 by aurora B regulates completion of
cytokinesis. Curr Biol. 15:778–786. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Capalbo L, Montembault E, Takeda T, Bassi
ZI, Glover DM and D’Avino PP: The chromosomal passenger complex
controls the function of endosomal sorting complex required for
transport-III Snf7 proteins during cytokinesis. Open Biol.
2:1200702012. View Article : Google Scholar
|
|
39
|
Xu Z, Vagnarelli P, Ogawa H, Samejima K
and Earnshaw WC: Gradient of increasing Aurora B kinase activity is
required for cells to execute mitosis. J Biol Chem.
285:40163–40170. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Guse A, Mishima M and Glotzer M:
Phosphorylation of ZEN-4/MKLP1 by aurora B regulates completion of
cytokinesis. Curr Biol. 15:778–786. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Baldini E, Arlot-Bonnemains Y, Mottolese
M, et al: Deregulation of Aurora kinase gene expression in human
testicular germ cell tumours. Andrologia. 42:260–267. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Graham PL, Yanowitz JL, Penn JK, Deshpande
G and Schedl P: The translation initiation factor eIF4E regulates
the sex-specific expression of the master switch gene Sxl in
Drosophila melanogaster. PLoS Genet. 7:e10021852011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nasr Z, Robert F, Porco JA Jr, Muller WJ
and Pelletier J: eIF4F suppression in breast cancer affects
maintenance and progression. Oncogene. Apr 9–2012.(Epub ahead of
print).
|
|
44
|
Ilic N, Utermark T, Widlund HR and Roberts
TM: PI3K-targeted therapy can be evaded by gene amplification along
the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis.
Proc Natl Acad Sci U S A. 108:E699–708. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Portella G, Passaro C and Chieffi P:
Aurora B: a new prognostic marker and therapeutic target in cancer.
Curr Med Chem. 18:482–496. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xie F, Lang Q, Zhou M, et al: The dietary
flavonoid luteolin inhibits Aurora B kinase activity and blocks
proliferation of cancer cells. Eur J Pharm Sci. 46:388–396. 2012.
View Article : Google Scholar : PubMed/NCBI
|
